Article Text

other Versions

Download PDFPDF
Drug monitoring in long-term treatment with adalimumab for juvenile idiopathic arthritis-associated uveitis
  1. Andrea Skrabl-Baumgartner1,
  2. Gerald Seidel2,
  3. Beate Langner-Wegscheider2,
  4. Axel Schlagenhauf1,
  5. Jörg Jahnel1
  1. 1Department of Pediatrics and Adolescent Medicine, Medical University Graz, Graz, Austria
  2. 2Department of Ophthalmology, Medical University Graz, Graz, Austria
  1. Correspondence to Dr Andrea Skrabl-Baumgartner, Department of Pediatrics, Medical University Graz, Graz 8036, Austria; andrea.skrabl-baumgartner{at}medunigraz.at

Footnotes

  • Contributors ASB conceptualised and designed the study and recruited patients and sampled data. ASB drafted the initial manuscript and revised the final manuscript. GS analysed the data and revised the manuscript. BLW and AS analysed the data. JJ helped in designing the study and reviewed the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained from the parents/guardian.

  • Ethics approval Ethics Committee at the Medical University of Graz.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors ASB conceptualised and designed the study and recruited patients and sampled data. ASB drafted the initial manuscript and revised the final manuscript. GS analysed the data and revised the manuscript. BLW and AS analysed the data. JJ helped in designing the study and reviewed the manuscript. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Obtained from the parents/guardian.

  • Ethics approval Ethics Committee at the Medical University of Graz.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles